Biomedical advances
Gene therapy explained: treating disease at its source
For a long time, medicine treated the consequences of genetic disease — managing symptoms while the underlying fault remained. Gene therapy aims at something more fundamental: fixing or compensating for the faulty gene itself. Once purely experimental, it now underpins approved treatments for several previously untreatable conditions. This guide explains how it works and what it can — and cannot yet — do.
Education and reference only. This article explains how treatments work in plain language — it contains no doses and is not a substitute for advice from your doctor or pharmacist. Always discuss your own treatment with a qualified clinician.
The basic idea
Many diseases are caused by a gene that is missing, broken, or working incorrectly. Gene therapy intervenes at that level. Broadly, there are a few strategies: adding a working copy of a gene to compensate for a faulty one; silencing a gene that is producing something harmful; or, with newer gene-editing tools, correcting the fault in the DNA directly. The goal is to address the root cause rather than manage the downstream effects for life.
How the genetic material is delivered
Getting genetic instructions into the right cells is the central challenge. The commonest method uses a modified, harmless virus (a viral vector) as a delivery vehicle — the virus is stripped of its ability to cause disease and loaded with the therapeutic gene. Treatment can be done inside the body (the vector is infused and finds its target cells) or outside it (cells such as bone-marrow stem cells are removed, modified in the lab, and returned). Non-viral methods, including lipid nanoparticles, are also used, particularly for RNA-based approaches.
What it already treats
Gene therapy is no longer hypothetical. Approved therapies exist for an inherited form of blindness, spinal muscular atrophy (a devastating condition in babies), certain immune deficiencies, and inherited blood disorders such as some forms of haemophilia and beta-thalassaemia. In several of these, a single treatment has produced dramatic, durable benefit where none existed before. The list is growing as more products complete trials and gain approval.
Gene therapy versus gene editing
It is worth distinguishing two overlapping ideas. Traditional gene therapy usually adds a functional gene without altering the existing DNA sequence. Gene editing — using tools such as CRISPR — makes precise changes to the DNA itself, correcting or disabling a specific sequence. Editing is powerful but raises additional considerations about precision and off-target effects. Importantly, current approved therapies target the body's ordinary (somatic) cells, so changes are not passed to future generations; editing that would be inherited (germline) is not permitted in clinical practice.
The promise and the limits
The promise is enormous: one-time treatments that correct the cause of a disease. The limits are real too. Delivery to the right cells remains imperfect, immune reactions to viral vectors can be a problem, long-term durability and safety need continued follow-up, and the treatments are extraordinarily expensive to develop and deliver — raising hard questions about access. For now, gene therapy is transforming outcomes in a growing set of specific, mostly rare, genetic diseases, with broader application an active and fast-moving frontier.
In short
Key takeaways
- Gene therapy targets the underlying genetic fault — adding a working gene, silencing a harmful one, or editing DNA directly.
- Genetic material is usually delivered by a modified harmless virus, inside or outside the body.
- Approved therapies already exist for inherited blindness, spinal muscular atrophy, some immune and blood disorders, and more.
- Gene editing (e.g. CRISPR) alters the DNA sequence itself; current clinical therapies affect only somatic cells and are not inherited.
- Challenges remain around delivery, immune reactions, durability and very high cost.
Answers
Frequently asked questions
Does gene therapy change genes I would pass to my children?
No. Approved gene therapies act on the body’s ordinary (somatic) cells, so changes are not passed to future generations. Inheritable (germline) editing is not permitted in clinical practice.
Is gene therapy a permanent cure?
For some conditions a single treatment has produced durable, life-changing benefit, but long-term durability varies by disease and continued follow-up is needed. It is not yet a cure for most genetic conditions.
What is the difference from CRISPR gene editing?
Traditional gene therapy usually adds a working gene without changing existing DNA; gene editing (such as CRISPR) makes precise changes to the DNA sequence itself.
Sources
Where this is drawn from
- NHS — Gene therapy and advanced therapy medicinal products (ATMPs)
- MHRA — Regulation of gene therapy medicinal products
- Nature / NEJM — reviews of approved gene therapies
Need clear, evidence-led health content?
We write accurate, dose-free patient information and medicines content for teams.